Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2021 / Cilt: 27 - Sayı: 1

Evaluation and Management of Women who Have Experienced Stillbirth in Their Previous Pregnancies

Pages
40–43
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Management of these patients with low-dose aspirin, low-dose low molecular weight heparin and corticosteroids seemed to be beneficial for increasing live birth rates and avoiding obstetric complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To evaluate the subsequent pregnancy outcomes of women who have experienced unexplained stillbirth in their previous gestations.
📊
Key Findings & Data:STUDY DESIGN: This retrospective cohort consisted of 14 pregnancies who had stillbirth (without known risk factors) in their previous pregnancies.
💡
Conclusion & Impact:Management of these patients with low-dose aspirin, low-dose low molecular weight heparin and corticosteroids seemed to be beneficial for increasing live birth rates and avoiding obstetric complications.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: To evaluate the subsequent pregnancy outcomes of women who have experienced unexplained stillbirth in their previous gestations. STUDY DESIGN: This retrospective cohort consisted of 14 pregnancies who had stillbirth (without known risk factors) in their previous pregnancies. These patients had been included in a special preconceptional care program to be evaluated in terms of etiological risk factors for stillbirth. At least one of the risk factors, such as methylenetetrahydrofolate reductase polymorphisms, hereditary thrombophilias and autoimmune problems, were defined in this study population. After detection of pregnancy, the patients were administered low-dose low-molecular-weight heparin (enoxaparin, 1×2000 Anti-XA IU/0.2 mL/day), low-dose salicylic acid (100 mg/day) and low-dose corticosteroid (methylprednisolone, 1×4 mg/day orally) in necessary cases. RESULTS: Out of 14 pregnancies, 4 (28.5%) ended up with miscarriages at 9, 11, 11 and 15 gestational weeks, respectively. The remaining 10 pregnancies ended up with alive deliveries. The mean gestational week at birth was 36.4±0.51, while the mean birthweight was 2882±381.01 g. Out of 10 pregnancies, only one was diagnosed as IUGR. Only two newborn necessitated hospitalization in the neonatal intensive care unit due to respiratory problems. Both newborns were discharged from the neonatal intensive care unit without any further complication at the post-partum 5th day. CONCLUSION: Patients with a prior stillbirth should be screened for methylenetetrahydrofolate reductase polymorphisms, autoimmune problems and hereditary thrombophilias, especially in case of absence of any etiological factor. Management of these patients with low-dose aspirin, low-dose low molecular weight heparin and corticosteroids seemed to be beneficial for increasing live birth rates and avoiding obstetric complications.

🔖

Cite This Article

FADİLOĞLU, E., Canan, C. (2021). Evaluation and Management of Women who Have Experienced Stillbirth in Their Previous Pregnancies. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 27 - Sayı: 1, 40–43. https://ajindex.com/articles/226945

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Joseph KS. Kinniburgh B. Hutcheon JA. Mehrabadi A. Dahlgren L. Basso M. et al. Rationalizing definitions and procedures for optimizing clinical care and public health in fetal death and stillbirth. Obstet Gynecol. 2015;125 (4):784-8. doi: 10.1097/AOG.0000000000000717
  2. Organization WH. International statistical classification of diseases and related health problems: World Health Organization; 2004
  3. Reddy UM. Management of pregnancy after stillbirth. Clin Obstet Gynecol. 2010;53(3):700-9. doi: 10.1097/ GRF.0b013e3181eba25e
  4. Ecevit A. Oguz SS. Tarcan A. Yazici C. Dilmen U. The changing pattern of perinatal mortality and causes of death in central Anatolian region of Turkey. J Matern Fetal Neonatal Med. 2012;25(9):1738-41. doi:10.3109/ 14767058.2012.663820
  5. Collaborators. GCM. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1725-1774. doi: 10.1016/S0140- 6736(16)31575-6
  6. Samueloff A. Xenakis E. Berkus M. Huff R. Langer O. Recurrent stillbirth. Significance and characteristics. J Reprod Med. 1993;38(11):883-6. PMID: 8277486
  7. Surkan PJ. Stephansson O. Dickman PW. Cnattingius S. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. N Eng J Med. 2004;350 (8):777-85. doi: 10.1056/NEJMoa031587
  8. Silver RM. Varner MW. Reddy U. Goldenberg R. Pinar H. Conway D. et al. Work-up of stillbirth: a review of the evidence. Am J Obsteta Gynecol. 2007;196(5):433-44. doi: 10.1016/j.ajog.2006.11.041
  9. Group SCRNW. Causes of death among stillbirths. JAMA 2011;306(22):2459-68. doi: 10.1001/jama.2011.1823
  10. Lockwood CJ. Heritable coagulopathies in pregnancy. Obstetric Gynecol Surv. 1999;54(12):754-65. doi:10. 1097/00006254-199912000-00004
  11. Grønbæk L. Vilstrup H. Jepsen P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Aliment Pharmacol Ther. 2018;48(6):655-663. doi: 10.1111/apt.14925
  12. Kos BJP. Leemaqz SY. McCormack CD. Andraweera PH. Furness DL. Roberts CT. et al. The association of parental methylenetetrahydrofolate reductase polymorphisms (MTHFR 677C> T and 1298A> C) and fetal loss: a casecontrol study in South Australia. J Matern Fetal Neonatal Med. 2020;33(5):752-757. doi:10.1080/14767058.2018. 1500546
  13. Gris JC. Mercier E. Quéré I. Lavigne-Lissalde G. Coc